Filter browse results

Total results with these characteristics: 102

Subject: Reproductive health > Cervical cancer prevention

Page 1 of 6
10 Key Findings and Recommendations for Effective Cervical Cancer Screening and Treatment Programs

In early 2007, partners of the Alliance for Cervical Cancer Prevention met to assess newly analyzed results of key studies in India, Peru, South Africa, and Thailand. These new data spurred the partners to outline ten key findings and recommendations for global policy and practice related to cervical cancer screening and treatment in low-resource settings.

Publication date: April 2007

Region: Global

ACCP Strategies for Supporting Women With Cervical Cancer

This report provides an overview of current issues relating to cancer treatment in developing countries, followed by descriptions of existing support for cancer patients in countries where ACCP has worked and the support provided by ACCP projects. Finally, this report provides recommendations, based on ACCP experiences, for the provision of basic assistance at the national or local level to women with cervical cancer, within the context of a prevention-based intervention in low-resource settings.

Author: White SC; Winkler JL; ACCP Community Involvement Affinity Group

Publication date: 2004

Region: Global

Alliance for Cervical Cancer Prevention Website

Launched in 2002, this website provides information on the Alliance for Cervical Cancer Prevention (ACCP), of which PATH was a member. Having accomplished its mission, the ACCP disbanded in 2013.

Publication date: 2013

Region: Global

Part of series: Websites

The Case for Investing in Cervical Cancer Prevention

This document provides evidence on cervical cancer's burden of disease and the importance of women

Author: Sherris J; Castro W; Levin C; Dzuba I; Arossi S

Publication date: 2004

Region: Global

Part of series: Cervical Cancer Prevention: Issues in Depth

Cervical Cancer Prevention at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers

Supported by a seed grant from the World Bank, PATH began to focus on cervical cancer in 1991. Since then, our portfolio has expanded tremendously, thanks in large part to grants from the Bill & Melinda Gates Foundation. In this report, we describe our key cervical cancer prevention initiatives.

Publication date: April 2013

Region: Global

Cervical Cancer Prevention in Western Province

This is one of a series of fact sheets that describe PATH's current and past work in Kenya. The fact sheets focus on specific projects as well as unique approaches that cut across projects. This fact sheet describes the work of the Western Kenya Cervical Cancer Prevention Project.

Publication date: June 2006

Region: Africa

Cervical Cancer Prevention Initiatives at PATH: Two Decades of Progress Toward a World Free of HPV-Related Cancers

PATH’s key areas of work in cervical cancer prevention are described in depth in this 12-page publication.

Publication date: August 2008

Region: Global

Cervical Cancer Project in Vietnam

This fact sheet provides an overview of PATH's work to prevent and treat cervical cancer in Vietnam, including human papillomavirus vaccine introduction research, vaccine demonstration, a screening and treatment pilot model, and advocacy.

Publication date: May 2011

Region: Asia

Cervical Cancer Screening and Treatment in Low-Resource Settings: Practical Experience From PATH

From 2006 to 2011, PATH conducted HPV vaccination demonstration projects in India, Peru, Uganda, and Vietnam to provide evidence for decision-making about public-sector introduction of human papillomavirus (HPV) vaccines. This report, part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website, examines the second component of a successful cervical cancer prevention program—screening and treatment of adult women for precancerous lesions.

Publication date: 2013

Region: Global

Cervical Cancer, Human Papillomavirus (HPV) and HPV Vaccines: Key Points for Policy-Makers and Health Professionals

This booklet summarizes and updates the World Health Organization (WHO) document Human Papillomavirus and HPV Vaccine: Technical Information for Policy-Makers and Health Professionals and the WHO/UNFPA guidance note Preparing for the Introduction of HPV Vaccines—Policy and Programme Guidance for Countries. They are available in the STIs/RTIs section of the WHO website.

Publication date: 2007

Region: Global

Conclusions From ACCP Clinical Research in Developing Countries

This ACCP Cervical Cancer Prevention Fact Sheet summarizes the major findings and conclusions from ACCP research on organized cervical cancer prevention programs, alternative screening methods, treatment methods for precancerous lesions, and cost-effectiveness of screen-and-treat programs.

Author: ACCP

Publication date: 2004

Region: Global

Conducting Formative Research for HPV Vaccination Program Planning: Practical Experience From PATH

This report is part of the Cervical Cancer Prevention: Practical Experience Series on the RHO Cervical Cancer website summarizing lessons learned to guide cervical cancer prevention program planning in low-resource settings. It demonstrates that formative research is a necessary component of overall planning, discusses formative research issues specific to cervical cancer, and explains how research results may be used for strategic planning within the cervical cancer context.

Publication date: 2012

Region: Global

Course in Visual Methods for Cervical Cancer Screening: Visual Inspection With Acetic Acid and Lugol's Iodine

This manual is designed for trainers of clinicians who perform vaginal speculum examination and screening methods to prevent cervical cancer. Please note that the online version is a preview. The complete CD-ROM may be ordered by emailing

Author: Sellors J

Publication date: December 2004

Region: Global

Cryotherapy for Cervical Cancer Prevention

Part of the Technology Updates series, this fact sheet describes PATH's work on cryotherapy for cervical cancer prevention.

Publication date: April 2012

Region: Global

Part of series: Technology Updates

Current and Future HPV Vaccines: Promise and Challenges

This 72-page document offers an in-depth look at vaccines against human papillomavirus (HPV), both currently available vaccines and those in development, including therapeutic vaccines. The document includes an examination of programmatic issues relevant to developing countries.

Author: Kols A

Publication date: 2006

Region: Global

Detection of High-Risk HPV-E6 Oncoprotein in Low and High-Grade Cervical Intraepithelial Neoplasia (CIN): Emerging Evidence for Predictive Validity

This poster demonstrates the predictive validity of an assay developed by Arbor Vita and PATH. For this study, cervical swab specimens collected from women screened, diagnosed, and managed in rural settings in China were tested for the presence of HPV-16 DNA then examined for HPV16-E6 expression. Results confirmed E6 is a potential diagnostic marker. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.

Author: Schweizer J, Somoza C, Mahoney C, et al

Publication date: September 2006

Region: Global

Developing a Lateral Flow Strip Test for E6 Oncoprotein to Identify Cervical Intraepithelial Neoplasia (CIN) at Increased Risk of Progression to Cervical Cancer

This poster outlines the evaluation of two immunochromatographic strip test platforms for the best limit of detection: one uses an antibody colloidal gold conjugate which is visually interpreted yielding qualitative results, and the other uses an antibody paramagnetic particle conjugate which is read by an instrument yielding quantitative results. The resulting limits of detection of these two methods are compared to the target limit of detection for an E6 assay of ~50 pg. Presented at: 23rd Papillomavirus Conference and Clinical Workshop, September 1, 2006; Prague, Czech Republic.

Author: Peck R, Weigl BH, Schweizer J, et al

Publication date: September 2006

Region: Global

Developing Cervical Cancer Screening Programs that Meet Women's Needs

Publication date: 2003

Region: Global

Development of a Diagnostic Assay Based on the Binding of High-Risk HPV-E6 Oncoproteins to PDZ

A prototype of a novel diagnostic assay for cervical pre-cancer and cancer has been developed in both a sandwich ELISA-based and a lateral flow–based format (“strip test”). The test specifically detects presence of high-risk HPV-E6 and therefore promises to be of higher predictive value for cervical pre-cancer and cancer than other assays detecting merely presence of HPV. Presented at: 22rd International Papillomavirus Conference and Clinical Workshop, September 1, 2006; Vancouver, Canada.

Author: Schweizer J, Somoza C, Peck R, et al

Publication date: September 2006

Region: Global

Directions in Global Health (Volume 1, Issue 3)

The September 2004 issue of PATH's programmatic newsletter focuses on five projects: PATH's Children's Vaccine Program, which is strengthening immunization in Senegal, Cambodia, and India; evaluation of the SolarChill refrigerator, which is using solar power to fuel the cold chain; our cervical cancer work in Kenya and Peru, as part of the Alliance for Cervical Cancer Prevention; the Program for Advancement of Commercial Technology–Child and Reproductive Health (PACT-CRH), which is transferring health technologies to India's private sector; and results from three evaluations of clean home delivery kits used in Nepal and Tanzania.

Author: PATH

Publication date: September 2004

Region: Global

Part of series: Directions in Global Health

Page 1 of 6